Abstract:According to numerous animal studies, adverse environmental stimuli, including physical, chemical, and biological factors, can cause low-grade chronic inflammation and subsequent tumor development. Human epidemiological evidence has confirmed the close relationship between chronic inflammation and tumorigenesis. However, the mechanisms driving the development of persistent inflammation toward tumorigenesis remain unclear. In this study, we assess the potential role of reactive oxygen species (ROS) and associated mechanisms in modulating inflammation-induced tumorigenesis. Recent reports have emphasized the cross-talk between oxidative stress and inflammation in many pathological processes. Exposure to carcinogenic environmental hazards may lead to oxidative damage, which further stimulates the infiltration of various types of inflammatory cells. In turn, increased cytokine and chemokine release from inflammatory cells promotes ROS production in chronic lesions, even in the absence of hazardous stimuli. Moreover, ROS not only cause DNA damage but also participate in cell proliferation, differentiation, and apoptosis by modulating several transcription factors and signaling pathways. We summarize how changes in the redox state can trigger the development of chronic inflammatory lesions into tumors. Generally, cancer cells require an appropriate inflammatory microenvironment to support their growth, spread, and metastasis, and ROS may provide the necessary catalyst for inflammation-driven cancer. In conclusion, ROS bridge the gap between chronic inflammation and tumor development; therefore, targeting ROS and inflammation represents a new avenue for the prevention and treatment of cancer.

Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer

Progress on the Role of Reactive Oxygen Species-Mediated Tumor Microenvironment in Pancreatic Cancer

Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment

Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway.

Identification of a novel reactive oxygen species (ROS)-related genes model combined with RT-qPCR experiments for prognosis and immunotherapy in gastric cancer

MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development

Association of Elevated Reactive Oxygen Species and Hyperthermia Induced Radiosensitivity in Cancer Stem-Like Cells

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Reactive Oxygen Species in Colorectal Cancer Adjuvant Therapies

Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer.

Reactive Oxygen Species and Colorectal Cancer

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Roles of Reactive Oxygen Species in Inflammation and Cancer

Recent Progress of the Tumor Microenvironmental Metabolism in Cervical Cancer Radioresistance

Activated HIF1α of Tumor Cells Promotes Chemoresistance Development Via Recruiting GDF15-producing Tumor-Associated Macrophages in Gastric Cancer.

Reactive Oxygen Species Mediate Oxaliplatin-Induced Epithelial-Mesenchymal Transition and Invasive Potential in Colon Cancer

Redox Regulation in Tumor Cell Epithelial–mesenchymal Transition: Molecular Basis and Therapeutic Strategy